These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 31002669)

  • 1. Prevalence and predictors for sustained remission in rheumatoid arthritis.
    Sung YK; Yoshida K; Prince FHM; Frits ML; Cho SK; Choe JY; Lee HS; Lee J; Lee SS; Yoo DH; Helfgott SM; Shadick NA; Weinblatt ME; Solomon DH; Bae SC
    PLoS One; 2019; 14(4):e0214981. PubMed ID: 31002669
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HAQ score is an independent predictor of sustained remission in patients with rheumatoid arthritis.
    Lee KE; Choi SE; Xu H; Kang JH; Park DJ; Lee SS
    Rheumatol Int; 2017 Dec; 37(12):2027-2034. PubMed ID: 28956118
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sex differences in clinical characteristics and their influence on clinical outcomes in an observational cohort of patients with rheumatoid arthritis.
    Shin S; Park EH; Kang EH; Lee YJ; Song YW; Ha YJ
    Joint Bone Spine; 2021 May; 88(3):105124. PubMed ID: 33346105
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sustained rheumatoid arthritis remission is uncommon in clinical practice.
    Prince FH; Bykerk VP; Shadick NA; Lu B; Cui J; Frits M; Iannaccone CK; Weinblatt ME; Solomon DH
    Arthritis Res Ther; 2012 Mar; 14(2):R68. PubMed ID: 22429277
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sustained drug-free remission in rheumatoid arthritis after DAS-driven or non-DAS-driven therapy: a comparison of two cohort studies.
    van der Woude D; Visser K; Klarenbeek NB; Ronday HK; Peeters AJ; Kerstens PJ; Dijkmans BA; Huizinga TW; van der Helm-van Mil AH; Allaart CF
    Rheumatology (Oxford); 2012 Jun; 51(6):1120-8. PubMed ID: 22337939
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overweight, Obesity, and the Likelihood of Achieving Sustained Remission in Early Rheumatoid Arthritis: Results From a Multicenter Prospective Cohort Study.
    Schulman E; Bartlett SJ; Schieir O; Andersen KM; Boire G; Pope JE; Hitchon C; Jamal S; Thorne JC; Tin D; Keystone EC; Haraoui B; Goodman SM; Bykerk VP;
    Arthritis Care Res (Hoboken); 2018 Aug; 70(8):1185-1191. PubMed ID: 29193840
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sustained Remission Improves Physical Function in Patients with Established Rheumatoid Arthritis, and Should Be a Treatment Goal: A Prospective Observational Cohort Study from Southern Sweden.
    Einarsson JT; Geborek P; Saxne T; Kristensen LE; Kapetanovic MC
    J Rheumatol; 2016 Jun; 43(6):1017-23. PubMed ID: 27036384
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the long-term outcome for patients with rheumatoid arthritis with persistent moderate disease activity or disease remission during the first year after diagnosis: data from the ESPOIR cohort.
    Combe B; Logeart I; Belkacemi MC; Dadoun S; Schaeverbeke T; Daurès JP; Dougados M
    Ann Rheum Dis; 2015 Apr; 74(4):724-9. PubMed ID: 24399234
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of and predictive factors for sustained disease-modifying antirheumatic drug-free remission in rheumatoid arthritis: results from two large early arthritis cohorts.
    van der Woude D; Young A; Jayakumar K; Mertens BJ; Toes RE; van der Heijde D; Huizinga TW; van der Helm-van Mil AH
    Arthritis Rheum; 2009 Aug; 60(8):2262-71. PubMed ID: 19644846
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sustained clinical remission of rheumatoid arthritis and its predictive factors in an unselected adult Chinese population from 2009 to 2018.
    Xie W; Li J; Zhang X; Sun X; Zhang Z
    Int J Rheum Dis; 2019 Sep; 22(9):1670-1678. PubMed ID: 31297977
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of different remission definitions on identification of predictors of both point and sustained remission in rheumatoid arthritis treated with anti-TNF therapy.
    Barnabe C; Homik J; Barr SG; Martin L; Maksymowych WP
    J Rheumatol; 2014 Aug; 41(8):1607-13. PubMed ID: 25028371
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic Factors for Sustained Remission in a "Real Life" Cohort of Rheumatoid Arthritis Patients.
    Acosta-Mérida Á; Naranjo A; Rodríguez-Lozano C
    Reumatol Clin (Engl Ed); 2020; 16(5 Pt 2):405-409. PubMed ID: 30482509
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictors of sustained remission in patients with early rheumatoid arthritis treated according to an aggressive treat-to-target protocol.
    Paulshus Sundlisæter N; Olsen IC; Aga AB; Hammer HB; Uhlig T; van der Heijde D; Kvien TK; Lillegraven S; Haavardsholm EA;
    Rheumatology (Oxford); 2018 Nov; 57(11):2022-2031. PubMed ID: 30053199
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sustained Remission in Tumor Necrosis Factor Inhibitor-treated Patients with Rheumatoid Arthritis: A Population-based Cohort Study.
    Einarsson JT; Geborek P; Saxne T; Kapetanovic MC
    J Rheumatol; 2015 May; 42(5):741-8. PubMed ID: 25684762
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The frequency of and risk factors for osteoporosis in Korean patients with rheumatoid arthritis.
    Lee JH; Sung YK; Choi CB; Cho SK; Bang SY; Choe JY; Hong SJ; Jun JB; Kim TH; Lee J; Lee HS; Yoo DH; Yoon BY; Bae SC
    BMC Musculoskelet Disord; 2016 Feb; 17():98. PubMed ID: 26912147
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of abatacept tapering therapy for sustained remission in patients with rheumatoid arthritis: Prospective single-center study.
    Yoshida S; Kotani T; Kimura Y; Matsumura Y; Yoshikawa A; Tokai N; Ozaki T; Nagai K; Takeuchi T; Makino S; Arawaka S
    Int J Rheum Dis; 2019 Jan; 22(1):81-89. PubMed ID: 30168272
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differences in Predictive Factors for Sustained Clinical Remission with Abatacept Between Younger and Elderly Patients with Biologic-naive Rheumatoid Arthritis: Results from the ABROAD Study.
    Sekiguchi M; Fujii T; Matsui K; Murakami K; Morita S; Ohmura K; Kawahito Y; Nishimoto N; Mimori T; Sano H;
    J Rheumatol; 2016 Nov; 43(11):1974-1983. PubMed ID: 27585689
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Window of opportunity to achieve major outcomes in early rheumatoid arthritis patients: how persistence with therapy matters.
    Contreras-Yáñez I; Pascual-Ramos V
    Arthritis Res Ther; 2015 Jul; 17(1):177. PubMed ID: 26162892
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictors of remission with etanercept-methotrexate induction therapy and loss of remission with etanercept maintenance, reduction, or withdrawal in moderately active rheumatoid arthritis: results of the PRESERVE trial.
    Smolen JS; Szumski A; Koenig AS; Jones TV; Marshall L
    Arthritis Res Ther; 2018 Jan; 20(1):8. PubMed ID: 29338762
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Earlier time to remission predicts sustained clinical remission in early rheumatoid arthritis--results from the Canadian Early Arthritis Cohort (CATCH).
    Kuriya B; Xiong J; Boire G; Haraoui B; Hitchon C; Pope J; Thorne JC; Tin D; Keystone EC; Bykerk V;
    J Rheumatol; 2014 Nov; 41(11):2161-6. PubMed ID: 25274902
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.